SEC fundamentals

BlossomHill Therapeutics, Inc. (BLSM)

as filed in 10-Q FY2026, period ended Sep 30, 2026 · updated Nov 14, 2026
Total Assets
$124.1M
Stockholders' Equity
$211.1M
Cash & Equivalents
$224.9M
Long-Term Debt
—

as filed in 10-Q FY2026, period ended Sep 30, 2026 · View filings on EDGAR ↗

Quarter-end price

Derived from SEC filings · not a live quote · USD per share

Sep 30, 2026
$21.34
As reported · as of Sep 28, 2026

Each price is as of its date, from the filings that reported it, and is never adjusted; the full series with each price's sources is in the docs.

In its 10-Q for the period ended Sep 30, 2026, BlossomHill Therapeutics, Inc. reported net income of -$24.0M and total assets of $124.1M. Every figure below is taken directly from BlossomHill Therapeutics, Inc.'s SEC filings: each links to the source document on EDGAR.

Recent SEC filings

Filed by the registrant · newest first · insider forms and holder schedules not included

FormFiledSource
8-KNov 12, 2026on EDGAR ↗
10-QNov 12, 2026on EDGAR ↗
10-QSep 18, 2026on EDGAR ↗
8-KSep 18, 2026on EDGAR ↗
8-KSep 15, 2026on EDGAR ↗
8-KAug 10, 2026on EDGAR ↗
S-1Jul 17, 2026on EDGAR ↗

All filings on EDGAR ↗

Balance Sheet

as of Sep 30, 2026 · 10-Q

Total Assets$124.1Msource ↗
Stockholders’ Equity$211.1Msource ↗
Cash & Equivalents$224.9Msource ↗
Long-Term Debt—source ↗

Income Statement

10-Q (quarterly) · period ended Sep 30, 2026

Revenue—source ↗
Net Income-$24.0Msource ↗
Operating Income-$25.5Msource ↗
Gross Profit—source ↗
Cost of Revenue—source ↗
R&D Expense$21.9Msource ↗

Per Share & Cash Flow

10-Q (quarterly) · period ended Sep 30, 2026

EPS (diluted)$-1.29source ↗
EPS (basic)$-1.29source ↗
Shares Outstanding31.8Msource ↗
Cash from Operations-$22.2Msource ↗
Cash from Financing$151.7Msource ↗
Cash from Investing$0source ↗

Insider activity

Form 4 open-market activity, last 180 days

Buys
6
Sells
0
Net shares
+948.9K

Restatement history

Point-in-time

No material restatements detected across 0 annual fact-keys: this company's as-filed numbers have held between filings. Point-in-time and as-of history are available via the API.

Deeper fundamentals

A free API key reaches BLSM’s revenue, margin and free-cash-flow trajectory (newest 3 fiscal years) and its leverage, liquidity and return ratios (newest 4 quarters). Starter extends the ratios to 20 quarters and adds the Piotroski F-score and accruals quality score; Analyst extends the trajectory to up to 20 years. As-of fundamentals at any past date are on Free too, up to 10 lookups a day; Starter removes that cap and adds the original-vs-restated detail, across the whole SEC universe.

Programmatic access

Everything on this page is served by the Distill API and by the MCP server at mcp.distillmarkets.com. A free key is issued at sign-up with no card; the full reference is in the docs.

These fundamentals, as filed
curl
curl -H "X-Api-Key: $DISTILL_API_KEY" \
https://api.distillmarkets.com/api/v1/sec/fundamentals/BLSM

MCP tool: get_sec_fundamentals ticker=BLSM

The same figures as they were known on any past date
curl
curl -H "X-Api-Key: $DISTILL_API_KEY" \
https://api.distillmarkets.com/api/v1/sec/fundamentals/BLSM/as-of/YYYY-MM-DD

MCP tool: get_asof_fundamentals ticker=BLSM as_of=YYYY-MM-DD

Quarter-end prices derived from SEC filings, with their sources and splits
curl
curl -H "X-Api-Key: $DISTILL_API_KEY" \
https://api.distillmarkets.com/api/v1/sec/prices/BLSM/history?frequency=quarter

MCP tool: get_sec_price_history ticker=BLSM frequency=quarter

Fiscal-year trajectory: revenue, margins, free cash flow
curl
curl -H "X-Api-Key: $DISTILL_API_KEY" \
https://api.distillmarkets.com/api/v1/sec/fundamentals/BLSM/history

MCP tool: get_fundamentals_history ticker=BLSM

Leverage, liquidity, margin and return ratios
curl
curl -H "X-Api-Key: $DISTILL_API_KEY" \
https://api.distillmarkets.com/api/v1/sec/financial-health/BLSM

MCP tool: get_financial_health ticker=BLSM

Not investment advice. Figures are shown as filed with the SEC; see the EDGAR source links for the original documents. Data may lag the latest filing.